Esperion Therapeutics Inc (NASDAQ:ESPR) shares, rose in value, with the stock price up by 6.73% to the previous day’s close as strong demand from buyers drove the stock to $2.22.
Actively observing the price movement in the recent trading, the stock is buoying the session at $2.08, falling within a range of $2.05 and $2.23. The value of beta (5-year monthly) is 0.954. Referring to stock’s 52-week performance, its high was $3.94, and the low was $1.58. On the whole, ESPR has fluctuated by 1.37% over the past month.
With the market capitalization of Esperion Therapeutics Inc currently standing at about $437.41 million, investors are eagerly awaiting this quarter’s results, scheduled for in February.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 327.41M, with a low estimate of 51.2M and a high estimate of 79M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 64.26M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ESPR’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ESPR currently trading nearly 0.18% and -9.69% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 47.30, while the 7-day volatility ratio is showing 8.39% which for the 30-day chart, stands at 6.80%. Furthermore, Esperion Therapeutics Inc (ESPR)’s beta value is 1.01, and its average true range (ATR) is 0.19.
A comparison of Esperion Therapeutics Inc (ESPR) with its peers suggests the former has fared considerably weaker in the market. ESPR showed an intraday change of 6.73% in today’s session so far, and over the past year, it grew by 4.23%%.
Data on historical trading for Esperion Therapeutics Inc (NASDAQ:ESPR) indicates that the trading volumes over the past 10 days have averaged 5.51 and over the past 3 months, they’ve averaged 6.21 million. According to company’s latest data on outstanding shares, there are 195.44 million shares outstanding.
Nearly 0.99% of Esperion Therapeutics Inc’s shares belong to company insiders and institutional investors own 65.92% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 32.35 million shares as on 2024-12-31, resulting in a short ratio of 3.9. According to the data, the short interest in Esperion Therapeutics Inc (ESPR) stood at 1646.00 of shares outstanding as of 2024-12-31; the number of short shares registered in 2024-11-29 reached 30.49 million. The stock has risen by 0.91% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ESPR stock heading into the next quarter.
